M. Chahal

Off-trial access to experimental cancer agents for the terminally ill: balancing the needs of individuals and society

M. Chahal, 2010, Journal of Medical Ethics.

Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making

Steven J. M. Jones, Richard A. Moore, E. Pleasance, 2018, Cold Spring Harbor molecular case studies.

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

J. Christensen, K. Famulski, M. Aghi, 2010, Neuro-oncology.

Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline

S. Yip, C. Hawkins, Sunit Das, 2022, Frontiers in Oncology.

Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management

B. Thiessen, C. Mariano, M. Chahal, 2022, Current oncology.

Treatment Patterns and Outcomes of Patients with Grade 4 Glioma Treated with Radiation during the COVID-19 Pandemic

A. Nichol, B. Thiessen, G. Aljawi, 2023, Current oncology.

Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphoma

L. Sehn, J. Connors, K. Savage, 2022, Leukemia & lymphoma.

O(6)-Methylguanine-DNA Methyltransferase Is a Novel Negative Effector of Invasion in Glioblastoma Multiforme

N. Stifani, M. Guiot, Yaoxian Xu, 2012, Molecular Cancer Therapeutics.